Skip to content

Oral Health in Covid-19 Survivors

Biomarkers of Oral Health in Covid-19 Survivors

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05205694
Acronym
ORFCovid
Enrollment
210
Registered
2022-01-25
Start date
2021-09-20
Completion date
2023-06-30
Last updated
2022-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Periodontitis

Brief summary

Aims are to assess periodontal health and salivary stress/ immunity responses in COVID-19 survivors

Detailed description

There are lack of data concerning oral health in COVID-19 survivors, nevertheless, many middle-aged patients with oral symptoms of Post-acute COVID-19 report xerostomia and taste impairment and suffer from oral hypofunction, thus may be susceptible to periodontitis and oral frailty. Post-acute or long COVID-19 is/would be the health hallmark of post-COVID-19 era, manifested as a multiplicity of clinical problems and requiring conceptual framework aiming at multidisciplinary health preserving activities. There are various factors which may affect oral and periodontal health in post-COVID-19 era, such as disruption of dental professional care due to the fear of infection, virus-induced disturbance of oral homeostasis and, as a common denominator- COVID-19-induced psychological stress. Expected results would not just offer epidemiological data but also, mechanistic background for defining risks and modified measures aiming to preserve oral health in post-COVID-19 era.

Interventions

None listed

Sponsors

University of Belgrade
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* self-reported good general health, ≥ 14 erupted teeth excluding third molars. For periodontally healthy: Bleeding on probing score ≤10%, without attachment loss and radiographic bone loss and probing depth ≤ 3 mm in every site (Trombelli L et al., 2018). For periodontitis patients: periodontitis in stages II-IV.

Exclusion criteria

* history of periodontal treatment in previous six months, acute oral infection, presence of systemic disease(s), pregnancy, lactation, smoking ≥ 10 cigarettes per day

Design outcomes

Primary

MeasureTime frameDescription
Periodontal disease stage and COVID 19one to six months after COVID-19Correlation periodontitis and COVID 19 infection

Secondary

MeasureTime frameDescription
Oral frailtyone to six months after COVID-19Oral frailty assessment in Covid 19 and Perio affected patients
psychological stressone to six months after COVID-19Assessment of psychological stress
salivary stress/immunity mediatorsone to six months after COVID-19Association of salivary stress/immunity mediators levels with perio disease in COVID 19 patients

Countries

Serbia

Contacts

Primary ContactJelena Roganović, Professor
jelena.roganovic@stomf.bg.ac.rs+381641976330

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026